Concepedia

Phase II study of weekly irinotecan and carboplatin for refractory or relapsed small-cell lung cancer

Nobuyuki Naka, Masaaki Kawahara, Kyoichi Okishio, Shigeto Hosoe, Mitsumasa Ogawara, Shinji Atagi, Yuuji Takemoto, Kiyonobu Ueno, Tomoya Kawaguchi, Kiyoyuki Furuse

Lung Cancer · 2002 · 50 citations · 12 references

DOI

Concepts

References

12

Irinotecan plus Cisplatin Compared with Etoposide plus Cisplatin for Extensive Small-Cell Lung Cancer

Kazumasa Noda, Yutaka Nishiwaki, Masaaki Kawahara et al. · New England Journal of Medicine · 2002 · 1.4K citations · Full text

, , +12

Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer

Joachim von Pawel, Joan H. Schiller, Frances A. Shepherd et al. · Journal of Clinical Oncology · 1999 · 960 citations

, , +12

CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer.

N Masuda, M. Fukuoka, Y Kusunoki et al. · Journal of Clinical Oncology · 1992 · 452 citations

, , +8

Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial.

David H. Johnson, F. Anthony Greco, John Strupp et al. · Journal of Clinical Oncology · 1990 · 220 citations

, , +14

Paclitaxel and Carboplatin in the Treatment of Small-Cell Lung Cancer Patients Resistant to Cyclophosphamide, Doxorubicin, and Etoposide: A Non–Cross-Resistant Schedule

Harry J.M. Groen, Eelco Fokkema, Bonne Biesma et al. · Journal of Clinical Oncology · 1999 · 114 citations

, , +14